LAMOTRIGINE EG 200 mg, dispersible or chewable tablet 30 tablets
Active ingredients: Lamotrigine
Commercialized according to BDPMDispensing in France: Prescription only
Dispersible or chewable tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LAMOTRIGINE EG 200 mg, comprimé dispersible ou à croquer
- Pharmaceutical form
- comprimé dispersible ou à croquer
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 11 Sept 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62578192CIP73786797CIP133400937867979Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LAMOTRIGINEcomprimé | 200 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.